Skip to main navigation Skip to search Skip to main content

Stromal lymphocytes are associated with upgrade of B3 breast lesions

  • Tanjina Kader
  • , Elena Provenzano
  • , Madawa W. Jayawardana
  • , Shona Hendry
  • , Jia Min Pang
  • , Kenneth Elder
  • , David J. Byrne
  • , Lauren Tjoeka
  • , Helen M.L. Frazer
  • , Eloise House
  • , Sureshni I. Jayasinghe
  • , Holly Keane
  • , Anand Murugasu
  • , Neeha Rajan
  • , Islam M. Miligy
  • , Michael Toss
  • , Andrew R. Green
  • , Emad A. Rakha
  • , Stephen B. Fox
  • , G. Bruce Mann
  • Ian G. Campbell, Kylie L. Gorringe

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Various histopathological, clinical and imaging parameters have been evaluated to identify a subset of women diagnosed with lesions with uncertain malignant potential (B3 or BIRADS 3/4A lesions) who could safely be observed rather than being treated with surgical excision, with little impact on clinical practice. The primary reason for surgery is to rule out an upgrade to either ductal carcinoma in situ or invasive breast cancer, which occurs in up to 30% of patients. We hypothesised that the stromal immune microenvironment could indicate the presence of carcinoma associated with a ductal B3 lesion and that this could be detected in biopsies by counting lymphocytes as a predictive biomarker for upgrade. A higher number of lymphocytes in the surrounding specialised stroma was observed in upgraded ductal and papillary B3 lesions than non-upgraded (p < 0.01, negative binomial model, n = 307). We developed a model using lymphocytes combined with age and the type of lesion, which was predictive of upgrade with an area under the curve of 0.82 [95% confidence interval 0.77–0.87]. The model can identify some patients at risk of upgrade with high sensitivity, but with limited specificity. Assessing the tumour microenvironment including stromal lymphocytes may contribute to reducing unnecessary surgeries in the clinic, but additional predictive features are needed.

Original languageEnglish
Article number115
Number of pages10
JournalBreast Cancer Research
Volume26
Issue number1
DOIs
Publication statusPublished - 8 Jul 2024
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Atypical ductal hyperplasia
  • B3 lesions
  • Biomarker
  • Ductal carcinoma in situ
  • Early breast neoplasia
  • Lesions of uncertain malignant potential
  • Stromal lymphocytes
  • Tumour infiltrating lymphocytes
  • Upgrade

Cite this